Calcineurin Inhibitor (CI) Use Reduces the Risk of...

Calcineurin Inhibitor (CI) Use Reduces the Risk of Donor-Specific Antibody (DSA) Development After Kidney and Kidney/pancreas Transplant.

Pelletier, R., Rajab, A., Henry, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
98
Journal:
Transplantation
DOI:
10.1097/00007890-201407151-00375
Date:
July, 2014
File:
PDF, 282 KB
2014
Conversion to is in progress
Conversion to is failed